TEL, a putative tumor suppressor, modulates cell growth and cell morphology of Ras-transformed cells while repressing the transcription of stromelysin-1

Molecular and Cellular Biology

Volumn 20, Issue 16, 2000, Pages 5828-5839

  Fenrick, R ^a   Wang, L ^a   Nip, J ^a   Amann, J M ^a   Rooney, R J ^a   Walker Daniels, J ^a   Crawford, H C ^a   Hulboy, D L ^a   Kinch, M S ^a   Matrisian, L M ^a   Hiebert, S W ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STROMELYSIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL AGGREGATION; CELL CULTURE; CELL GROWTH; CELL STRUCTURE; ENZYME ACTIVITY; GENE EXPRESSION; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

3T3 CELLS; ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; GENES, RAS; GENES, TUMOR SUPPRESSOR; MATRIX METALLOPROTEINASE 3; MICE; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0033858441     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.16.5828-5839.2000     Document Type: Article

References (80)

1. Replication of nodamura virus after transfection of viral RNA into mammalian cells in culture
2. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
3. The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner
4. Cytoskeletal and adhesion proteins as tumor suppressors
5. Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells
6. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
7. The effect of interferon-alpha on beta-1 integrin mediated adhesion and growth regulation in chronic myelogenous leukemia
8. Differences in the repertoires of basement membrane degrading enzymes in two carcinoma sublines with distinct patterns of site-selective metastasis
9. Focal adhesions, contractility, and signaling
10. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex
11. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene
12. Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1
13. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A
14. Changing views of the role of matrix metalloproteinases in metastasis
15. Influence of Ras and retinoic acid on nerve growth factor induction of transin gene expression in PC12 cells
16. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells
17. Cancer. Proteases - Invasion and more
18. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter
19. The role of histone deacetylases in acute leukemia
20. Both Tel and AML-1 contribute repression domains to the t(12;21) fusion protein
21. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation
22. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
23. The TEL gene and human leukemia
24. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
25. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
26. Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms
27. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
28. Specificity within the ets family of transcription factors
29. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
30. Cell adhesion: The molecular basis of tissue architecture and morphogenesis
31. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: Evidence for two new tumour-suppressor genes
32. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription
33. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line
34. Alterations in differentiation and behavior of monocytic phagocytes in transgenic mice that express dominant suppressors of ras signaling
35. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein
36. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines
37. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia
38. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
39. Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression
40. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells
41. The MYND motif is required for repression of basal transcription from the multidrug resistance-1 promoter by the t(8;21) fusion protein
42. ETO, a target of the t(8;21) in acute leukemia, interacts with N- CoR, mSin3, and histone deacetylases
43. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C
44. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
45. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells
46. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells
47. Control of epitheliomesenchymal transformation II. Cross-modulation of cell adhesion and cytoskeletal systems in embryonic neural cells
48. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways
49. Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun
50. The novel activation of ABL by fusion to an ets-related gene, TEL
51. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
52. New insights on DNA recognition by ets proteins from the crystal structure of the PU.1 ETS domain-DNA complex
53. The TEL gene products: Nuclear phosphoproteins with DNA binding properties
54. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia
55. An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites
56. Soft agar growth assays for transforming growth factors and mitogenic peptides
57. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia
58. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies
59. Structural organization and chromosomal localization of the mouse collagenase type I gene
60. Integrins: Emerging paradigms of signal transduction
61. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis
62. p27/Kip1 mutation found in breast cancer
63. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood
64. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia
65. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
66. Acute lymphoblastic leukemia of childhood: Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1
67. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
68. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV
69. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
70. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat
71. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL
72. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow
73. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway
74. The Ets family of transcription factors
75. Reversion of Ras transformed cells by Ets transdominant mutants
76. ECM and cell surface proteolysis: Regulating cellular ecology
77. The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation
78. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocyte differentiation
79. The ETV6, CDKN1B and D12S178 loci are involved in a segment commonly deleted in various 12p aberration in different hematological malignancies
80. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2